Spyre Therapeutics (NASDAQ:SYRE) CEO Sells $1,380,150.00 in Stock
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CEO Cameron Turtle sold 15,000 shares of the company’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $92.01, for a total value of $1,380,150.00. Following the sale, the chief executive officer owned 537,540 shares in the company, valued […]
5 Oct 04:08 · The Cerbat Gem